title: Phase I trial improvement: a question of patient selection, trial design, or both?
authors.affiliation: Mayo Clinic, Rochester, MN.
authors.forename: Karla V
authors.initials: KV
authors.lastname: Ballman
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D006801:Humans; D049451:Nomograms
chemical_list: D000970:Antineoplastic Agents